Pathology
 |
|
1 february 2023 16:59:04 |
| Real-world systemic sequential therapy with regorafenib for recurrent hepatocellular carcinoma: analysis of 93 cases from a single center (BMC Gastroenterology) |
|
Tweet Regorafenib is an oral multikinase inhibitor and became the first second-line systemic treatment for hepatocellular carcinoma (HCC) following the phase III RESORCE trial. This single-center study retrospective... |
| 124 viewsCategory: Pathology |
 The association of diabetes status and bone mineral density among US adults: evidence from NHANES 2005–2018 (BMC Endocrine Disorders)Study on the correlation between the severity of patellofemoral arthritis and the morphology of the distal femur (BMC Musculoskeletal Disorders) 
|
| blog comments powered by Disqus |
MyJournals.org
The latest issues of all your favorite science journals on one page
The latest issues of all your favorite science journals on one page
